Immunogenicity of BNT162b2 mRNA SARS-CoV-2 vaccine in patients with psoriatic arthritis on TNF inhibitors

BACKGROUND: Scanty data on the immunogenicity of the BNT162b2 vaccine in patients with psoriatic arthritis (PsA) on Tumor Necrosis Factor inhibitors (TNFi) have been published. OBJECTIVE: To investigate the humoral response to BNT162b2 vaccination patients with PsA on TNFi, comparing immunogenicity...

Descripción completa

Detalles Bibliográficos
Autores principales: Venerito, Vincenzo, Stefanizzi, Pasquale, Fornaro, Marco, Cacciapaglia, Fabio, Tafuri, Silvio, Perniola, Simone, Iannone, Florenzo, Lopalco, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Infections
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065766/
https://www.ncbi.nlm.nih.gov/pubmed/34987092
http://dx.doi.org/10.1136/rmdopen-2021-001847

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9065766/
https://www.ncbi.nlm.nih.gov/pubmed/34987092
http://dx.doi.org/10.1136/rmdopen-2021-001847

Ejemplares similares